Pharmacokinetics of first-line antituberculosis drugs in HIV-infected children with tuberculosis treated with intermittent regimens in India.
about
Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment Guidelines.A Long-term Co-perfused Disseminated Tuberculosis-3D Liver Hollow Fiber Model for Both Drug Efficacy and Hepatotoxicity in BabiesDrug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests.Pharmacokinetics of the First-Line Antituberculosis Drugs in Ghanaian Children with Tuberculosis with or without HIV CoinfectionAntituberculosis drugs in children.A Critical Review of the Current Evidence for Measuring Drug Concentrations of First-Line Agents Used to Treat Tuberculosis in Children.Evaluation of the Adequacy of the 2010 Revised World Health Organization Recommended Dosages of the First-line Antituberculosis Drugs for Children.The challenges of pharmacokinetic variability of first-line anti-TB drugs.Revisiting the mutant prevention concentration to guide dosing in childhood tuberculosis.Pharmacokinetics of First-Line Antituberculosis Drugs Using WHO Revised Dosage in Children With Tuberculosis With and Without HIV Coinfection.Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis.Suboptimal Antituberculosis Drug Concentrations and Outcomes in Small and HIV-Coinfected Children in India: Recommendations for Dose Modifications.
P2860
Q36730120-4020E84A-1855-4FE7-9E1B-4F6BEE20558FQ36869913-06BF0E67-1765-4ABB-9126-E9BF0B91EAD0Q37339268-7B5008C3-7E29-409C-8C36-A327F91677F9Q37613004-FCD2C7BC-A379-4DF1-85FF-3B2E1A01BF0BQ38533435-C476B7F7-6F2C-411D-A748-CF4FE4D0EEFCQ38547708-5D4551EE-683C-4EF8-B539-1A6DB410DCF8Q38673843-1599DE89-AADD-4989-AD0D-056BA52DE443Q38977166-AD634D0F-C0DB-415F-B2CC-BCE0F47C4E93Q40282057-E030E48C-EAA4-41FD-A5F2-3380BD0DC6B7Q40500659-3BD0859C-A242-418D-8404-E94F6FCDD2B5Q46679475-8FE70EA9-85EC-430A-852E-E76E47F8D004Q47778426-DF2A0186-613C-4487-8137-7F2DD40C106C
P2860
Pharmacokinetics of first-line antituberculosis drugs in HIV-infected children with tuberculosis treated with intermittent regimens in India.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pharmacokinetics of first-line ...... ntermittent regimens in India.
@ast
Pharmacokinetics of first-line ...... ntermittent regimens in India.
@en
type
label
Pharmacokinetics of first-line ...... ntermittent regimens in India.
@ast
Pharmacokinetics of first-line ...... ntermittent regimens in India.
@en
prefLabel
Pharmacokinetics of first-line ...... ntermittent regimens in India.
@ast
Pharmacokinetics of first-line ...... ntermittent regimens in India.
@en
P2093
P2860
P921
P356
P1476
Pharmacokinetics of first-line ...... ntermittent regimens in India.
@en
P2093
A K Hemanth Kumar
G Mathevan
G N Sanjeeva
Geetha Ramachandran
N Poorana Gangadevi
N Ravichandran
P K Bhavani
Rajeshwar Dayal
S Ramesh Kumar
P2860
P304
P356
10.1128/AAC.04338-14
P407
P577
2014-12-08T00:00:00Z